ProQR Therapeutics (PRQR) Common Equity (2013 - 2026)
ProQR Therapeutics' Common Equity came in at $92.38 million for the quarter ended Jun 30, 2026, up 21.8% from $75.82 million a year earlier and up 109.9% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Common Equity (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, ProQR Therapeutics' Common Equity was $55.78 million, down 41.8% from the prior year.
- Common Equity carries a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
- Going back by year, Common Equity was $95.85 million in the year ended Dec 31, 2024 (+114.1%), $44.77 million in the year ended Dec 31, 2023 (-36.3%), $70.28 million in the year ended Dec 31, 2022 (-48.0%) and $135.04 million in the year ended Dec 31, 2021 (+109.2%).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Common Equity since the quarter ended Dec 31, 2024.
- Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 47.4%.
- The fastest year-over-year change in Common Equity over five years came in the quarter ended Sep 30, 2025 (growth of 143.2%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 54.6%).
- Business Quant data shows PRQR's Common Equity at $44.02 million (quarter ended Mar 31, 2026), $57.47 million (quarter ended Dec 31, 2025) and $66.72 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | ProQR Therapeutics | 173.85 Mn | -289.75 Mn | - | 92.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.38 Mn |
| Mar 31, 2026 | 44.02 Mn |
| Dec 31, 2025 | 57.47 Mn |
| Sep 30, 2025 | 66.72 Mn |
| Jun 30, 2025 | 75.82 Mn |
| Mar 31, 2025 | 83.03 Mn |
| Dec 31, 2024 | 94.63 Mn |
| Sep 30, 2024 | 27.44 Mn |
| Jun 30, 2024 | 35.38 Mn |
| Mar 31, 2024 | 37.83 Mn |
| Dec 31, 2023 | 44.53 Mn |
| Sep 30, 2023 | 50.45 Mn |
| Jun 30, 2023 | 56.08 Mn |
| Mar 31, 2023 | 63.01 Mn |
| Dec 31, 2022 | 68.03 Mn |
| Sep 30, 2022 | 68.58 Mn |
| Jun 30, 2022 | 95.37 Mn |
| Mar 31, 2022 | 113.84 Mn |
| Dec 31, 2021 | 130.54 Mn |
| Sep 30, 2021 | 150.97 Mn |
API Access
ProQR Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();